Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre
Background: Voltage-gated potassium channel (VGKC)-complex antibodies can be associated with a range of immunotherapy-responsive clinical presentations including limbic encephalitis, Morvan 's syndrome and acquired neuromyotonia. However, there are patients with positive levels in whom the sign...
Main Authors: | Paterson, R, Zandi, MS, Armstrong, R, Vincent, A, Schott, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2014
|
Similar Items
-
Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.
by: Paterson, R, et al.
Published: (2014) -
Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody.
by: Pakozdy, A, et al.
Published: (2013) -
The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease
by: Seymour, A, et al.
Published: (2004) -
Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
by: Lang, B, et al.
Published: (2017) -
VGKC-complex antibody encephalitis.
by: Willis, MD, et al.
Published: (2014)